Logo image
Clinical Utility and Safety of Fecal Microbiota Transplantation to Children with Refractory Ulcerative Colitis
Journal article   Peer reviewed

Clinical Utility and Safety of Fecal Microbiota Transplantation to Children with Refractory Ulcerative Colitis

Toshifumi Yodoshi, Itaru Iwama, Kaoru Kikuchi, Masato Katsuren, Ruriko Izumikawa and Yukiko Gibu
Journal of Japanese Society for Parenteral and Enteral Nutrition, Vol.33(3), pp.881-887
2018
DOI: 10.11244/jspen.33.881

View Online

Abstract

Objective: The purpose of this study was to clarify the clinical utility of fecal microbiota transplantation (FMT) to children with severe refractory UC.Patients and methods: A single-center, descriptive study was undertaken between August 2015 and July 2017 at Okinawa Chubu Hospital. FMT was performed in four patients with refractory UC (2–14 years old) who had not responded to infliximab, cyclosporin, tacrolimus, or leukocytapheresis. Three of the patients were administered the FMT via elemental diet tubes, whereas the fourth received the FMT via colonoscopy. The following variables were evaluated using the patients' medical records: age, medication history, route of FMT administration, clinical course, PUCAI (Pediatric Ulcerative Colitis Activity Index) scores and FMT's complications.Results: One patient experienced clinical remission for 24 months, and two patients experienced clinical remission for a few weeks. No severe complications occurred.Conclusion: FMT appears to be safe for children with severe refractory UC. FMT may have utility as a temporizing induction therapy for severe refractory UC prior to the ultimately necessary step of surgery.
fecal microbiota fecal microbiota transplantation pediatric ulcerative colitis

Details

Metrics

1 Record Views
Logo image